Dear Readers: Please note that, in the Drugs and Pharmacology article, “A Systematic Review of the Efficacy and Safety of Atypical Antipsychotics in Patients with Psychological and Behavioral Symptoms of Dementia,” published in J Am Geriatr Soc 2006;54:354–361, on p 359, column 2, under the subheading “Long-Term Safety,” in the first paragraph, in the middle of line 4, it begins, “In risperidone trials,” Instead, it should read, “In olanzapine trials,” Also, in line 6, it reads, “In olanzapine trials.” Instead, it should read, “In risperidone trials.”